Trial · NCT04370548
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Patients With Clinical Cure at the TOC Visit (Day 21-30). | Visit 3 Day 21-30 post randomization | Clinical cure is defined as: * Resolution of the abnormal vaginal discharge associated with BV; * Negative 10% KOH "whiff test;" and * Clue cells \< 20% of the total epithelial cells in the saline wet mount. |
| Secondary | Number of Patients With Clinical Cure at the Interim Assessment Visit (Day 7-14). | Visit 2 Day 7-14 post randomization | |
| Secondary | Number of Patients With Bacteriological Cure at the TOC Visit (Day 21-30). | Visit 3 Day 21-30 post randomization | Bacteriological cure is defined as a Nugent score \< 4 |
| Secondary | Number of Patients With Bacteriological Cure at Interim Assessment Visit, Day 7-14 | Visit 2, Days 7-14 post randomization | |
| Secondary | Number of Patients With Therapeutic Cure at the TOC Visit (Day 21-30). | Visit 3 Day 21-30 post randomization | |
| Secondary | Number of Patients With Therapeutic Cure at the Interim Assessment Visit (Day 7-14). | Visit 2 Day 7-14 post randomization | |
| Other | Number of Patients With Clinical Cure at the Test of Cure Visit (21-30) | Visit 3, Days 21-30 post randomization | |
| Other | Number of Patients With Clinical Cure at Interim Assessment Visit, Days 7-14, PP Population | Visit 2, Days 7-14 post randomization | |
| Other | Number of Patients With Bacteriological Cure at Test of Cure Visit, Days 21-30, PP Population | Visit 3, Days 21-30 post randomization | |
| Other | Number of Patients With Bacteriological Cure, Interim Assessment Visit, Days 7-14, PP Population | Visit 2, Days 7-14 post randomization | |
| Other | Number of Patients With Therapeutic Cure at Test of Cure Visit, Days 21-30; PP Population | Visit 3, Days 21-30 post randomization | |
| Other | Number of Patients With Therapeutic Cure, Interim Assessment Visit, Days 7-14, PP Population | Visit 2, Days 7-14 post randomization |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04370548/registered